![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Huahai Pharmaceutical Co., Ltd. Linhai Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Losartan potassium, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2009-296 - Rev 01
This Chemical Type CEP, issued on April 26, 2019, remains in force until September 15, 2020, ensuring its reliability within the pharmaceutical industry.
Substance Number 2232 associated with this CEP further emphasizes